With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

KwaZulu-Natal Health Department reports significant stabilisation in medicine availability, while grappling with critical ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold to US consumers.

Study Links Ozempic to Hair Loss in Women There have been ongoing discussions online about a potential link between Ozempic and hair loss, akin to other alleged side effects of the medication such as ...

Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine (NEJM) of positive results from the ...

At West Buttermilk ­Estate, the multimillion-dollar Aspen home of James Packer, stunning views from floor-to-ceiling windows ...

Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

Job seekers are frustrated, women face barriers to success, and AI is creating new tensions in the workforce: Those stories ...